Patient Guide: A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05687032
Status: ACTIVE_NOT_RECRUITING
Condition: Acute Lymphoblastic Leukemia
Phase: PHASE4

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Beijing, Beijing
  • • Fuzhou, Fujian
  • • Guangzhou, Guangdong
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia - Join Clinical Trial NCTNCT05687032

How to Join This Clinical Trial - NCTNCT05687032

Learn how to participate in this PHASE4 trial studying an investigational therapy for Acute Lymphoblastic Leukemia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Lymphoblastic Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Lymphoblastic Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05687032 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing 100191 - China

Status: Contact for availability

Clinical Research Site

Fuzhou, Fujian 350000 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510180 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510515 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510700 - China

Status: Contact for availability

Clinical Research Site

Harbin, Heilongjiang 150010 - China

Status: Contact for availability

Clinical Research Site

Zhengzhou, Henan 450008 - China

Status: Contact for availability

Clinical Research Site

Wuhan, Hubei 430022 - China

Status: Contact for availability

Clinical Research Site

Wuhan, Hubei 430030 - China

Status: Contact for availability

Clinical Research Site

Suzhou, Jiangsu 215006 - China

Status: Contact for availability

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Acute Lymphoblastic Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships